Advanced search
Publication Cover
OncoImmunology Volume 12, 2023 - Issue 1
Submit an article Journal homepage
1,670
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition

Tom van den Endea Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands;b Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The NetherlandsCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2830-2310View further author information
ORCID Icon,
Aiarpi Ezdoglianc Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands;d Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Rheumatology and Clinical Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands;e Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The NetherlandsView further author information
,
Lisanne M. Baasc Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands;e Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The NetherlandsView further author information
,
Joyce Bakkerc Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands;e Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The NetherlandsView further author information
,
Sinéad M. Lougheedc Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands;e Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The NetherlandsView further author information
,
Micaela Harrasserc Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands;e Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands;f Oncode Institute, Utrecht, The NetherlandsView further author information
,
Cynthia Waasdorpe Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands;f Oncode Institute, Utrecht, The Netherlands;g Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsView further author information
,
Mark I. van Berge Henegouwenh Department of Surgery, Amsterdam Umc, University of Amsterdam, Amsterdam, The Netherlands;i Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The NetherlandsView further author information
,
Maarten C.C.M. Hulshofi Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands;j Department of Radiotherapy, Amsterdam Umc, University of Amsterdam, Amsterdam, The NetherlandsView further author information
,
Nadia Haj Mohammadk Department of Medical Oncology, UMC Utrecht, Utrecht University, Utrecht, The NetherlandsView further author information
,
Richard van Hillegersbergl Department of Surgery, UMC Utrecht, Utrecht University, Utrecht, The NetherlandsView further author information
,
Stella Mookm Department of Radiotherapy, UMC Utrecht, Utrecht University, Utrecht, The NetherlandsView further author information
,
Conny J. van der Lakend Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Rheumatology and Clinical Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, The NetherlandsView further author information
,
Nicole C.T. van Griekene Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands;n Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsView further author information
,
Sarah Derksc Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands;e Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands;f Oncode Institute, Utrecht, The NetherlandsView further author information
,
Maarten F. Bijlsmae Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands;f Oncode Institute, Utrecht, The Netherlands;g Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsView further author information
,
Hanneke W.M. van Laarhovena Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands;b Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The NetherlandsView further author information
&
Tanja D. de Gruijlc Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands;e Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The NetherlandsView further author information
 show all
Article: 2233403 | Received 03 Mar 2023, Accepted 02 Jul 2023, Published online: 17 Jul 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.